CDK5 and Alzheimer disease: Beyond synaptic dysfunction, the sustained presence of SASP mediators promotes τ hyperphosphorylation, a hallmark of Alzheimer’s disease, through the dysregulation of kinases such as glycogen synthase kinase 3β (GSK-3β) and cyclin-dependent kinase 5 (CDK5).